Inovio Pharmaceuticals Inc (INO):企業の財務・戦略的SWOT分析

◆英語タイトル:Inovio Pharmaceuticals Inc (INO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH4623FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Inovio Pharmaceuticals Inc (INO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Inovio Pharmaceuticals Inc (Inovio) is a biotechnology company that focuses on developing a portfolio of DNA immunotherapies and vaccines for the treatment and prevention of various cancers and infectious diseases. The company develops products based on its core SynCon DNA plasmid technology and electroporation delivery technology. The company’s product pipeline includes VGX-3100 for the treatment of cervical HSIL, vulvar HSIL, anal HSIL; INO-5401for glioblastoma; INO-3107 for recurrent respiratory papillomatosis (RRP); MEDI0457 for head and neck cancer and INO-5151 for the treatment of Prostate cancer. The company also has platform development programs in partnerships with several companies and government bodies focused at developing therapeutics for infectious diseases such as HIV, ebola, zika virus, middle east respiratory syndrome (MERS), lassa fever and COVID-19 disease. Inovio is headquartered in Plymouth Meeting, Pennsylvania, the US.

Inovio Pharmaceuticals Inc Key Recent Developments

Mar 15,2021: INOVIO announces the appointment of Michael Cordera as Executive Vice President & General Counsel
Mar 01,2021: INOVIO reports fourth quarter 2020 and year-end financial results
Feb 16,2021: INOVIO to Report Fourth Quarter and Full Year 2020 Financial Results on March 1, 2021
Dec 04,2020: Inovio enters Covid-19 vaccine development deal with Kaneka Eurogentec
Nov 09,2020: INOVIO reports third quarter 2020 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Inovio Pharmaceuticals Inc – Key Facts
Inovio Pharmaceuticals Inc – Key Employees
Inovio Pharmaceuticals Inc – Key Employee Biographies
Inovio Pharmaceuticals Inc – Major Products and Services
Inovio Pharmaceuticals Inc – History
Inovio Pharmaceuticals Inc – Company Statement
Inovio Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Inovio Pharmaceuticals Inc – Business Description
Inovio Pharmaceuticals Inc – Corporate Strategy
Inovio Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Inovio Pharmaceuticals Inc – Strengths
Inovio Pharmaceuticals Inc – Weaknesses
Inovio Pharmaceuticals Inc – Opportunities
Inovio Pharmaceuticals Inc – Threats
Inovio Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Inovio Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 15, 2021: INOVIO announces the appointment of Michael Cordera as Executive Vice President & General Counsel
Mar 01, 2021: INOVIO reports fourth quarter 2020 and year-end financial results
Feb 16, 2021: INOVIO to Report Fourth Quarter and Full Year 2020 Financial Results on March 1, 2021
Dec 04, 2020: Inovio enters Covid-19 vaccine development deal with Kaneka Eurogentec
Nov 09, 2020: INOVIO reports third quarter 2020 financial results
Aug 10, 2020: INOVIO reports second quarter 2020 financial results; provides DNA medicines clinical program mid-year update
Jun 04, 2020: VGXI’s Statement on the Recent Litigation Involving Inovio Pharmaceuticals in Pennsylvania State Court
May 26, 2020: INOVIO to host webinar “DNA Medicines: From COVID-19 to Cancer”
May 11, 2020: INOVIO reports first quarter 2020 financial results; provides business update
Apr 02, 2020: Australia’s CSIRO starts first stage of coronavirus vaccine testing
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Inovio Pharmaceuticals Inc, Key Facts
Inovio Pharmaceuticals Inc, Key Employees
Inovio Pharmaceuticals Inc, Key Employee Biographies
Inovio Pharmaceuticals Inc, Major Products and Services
Inovio Pharmaceuticals Inc, History
Inovio Pharmaceuticals Inc, Other Locations
Inovio Pharmaceuticals Inc, Subsidiaries
Inovio Pharmaceuticals Inc, Key Competitors
Inovio Pharmaceuticals Inc, Ratios based on current share price
Inovio Pharmaceuticals Inc, Annual Ratios
Inovio Pharmaceuticals Inc, Annual Ratios (Cont...1)
Inovio Pharmaceuticals Inc, Interim Ratios
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Inovio Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Inovio Pharmaceuticals Inc (INO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Seattle Genetics Inc (SGEN):企業の財務・戦略的SWOT分析
    Seattle Genetics Inc (SGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • EyeGate Pharmaceuticals Inc (EYEG)-医療機器分野:企業M&A・提携分析
    Summary EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical company that offers eye care medicines. The company offers macular edema and non-infectious anterior uveitis. It offers technologies for most prevalent issues in ophthalmic care; the existing lack of patient a …
  • Genetic Analysis AS:製品パイプライン分析
    Summary Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company that mapping of microbiota by utilizing the GA-map technology to develop IVD tests in various diseases. The company develops gene-based routine tests for the mapping and diagnosis of diseases related to dysbiosis and ba …
  • Chiesi USA Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Chiesi USA Inc (Chiesi USA), a subsidiary of Chiesi Farmaceutici S.p.A, is a specialty pharmaceutical company. It researches, develops, produces and commercializes therapies in cardiovascular, respiratory, neonatology, rare disease and special care therapeutics. The company's product portfol …
  • Tokyu Corp:企業の戦略・SWOT・財務分析
    Tokyu Corp - Strategy, SWOT and Corporate Finance Report Summary Tokyu Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Boston Children’s Hospital:企業の戦略的SWOT分析
    Boston Children's Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Indian Bank:企業の戦略・SWOT・財務情報
    Indian Bank - Strategy, SWOT and Corporate Finance Report Summary Indian Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Johnson Electric Holdings Limited:企業の戦略・SWOT・財務情報
    Johnson Electric Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Johnson Electric Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • ICU Medical Inc (ICUI):医療機器:M&Aディール及び事業提携情報
    Summary ICU Medical Inc (ICU Medical) is a medical device company which develops, manufactures, distributes and sells devices used for infusion therapy, cancer diagnosis and treatment and critical care applications. The company’s major products include needle free vascular access devices, closed sys …
  • Immunovia AB (IMMNOV):企業の製品パイプライン分析
    Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease …
  • AxoGen Inc (AXGN)-医療機器分野:企業M&A・提携分析
    Summary AxoGen Inc (AxoGen), formerly LecTec Corp is a provider of surgical solutions for peripheral nerve injuries. The company offers AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products. It also offers clinical researc …
  • BE Semiconductor Industries N.V. (BESI):企業の財務・戦略的SWOT分析
    BE Semiconductor Industries N.V. (BESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Baltika Breweries LLC:戦略・SWOT・企業財務分析
    Baltika Breweries LLC - Strategy, SWOT and Corporate Finance Report Summary Baltika Breweries LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Nippon Paint Holdings Co Ltd (4612):企業の財務・戦略的SWOT分析
    Nippon Paint Holdings Co Ltd (4612) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Banco Occidental de Descuento:企業の戦略・SWOT・財務情報
    Banco Occidental de Descuento - Strategy, SWOT and Corporate Finance Report Summary Banco Occidental de Descuento - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Royal Mail Plc (RMG):企業の財務・戦略的SWOT分析
    Royal Mail Plc (RMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • CIMIC Group Ltd (CIM):企業の財務・戦略的SWOT分析
    CIMIC Group Ltd (CIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Origin Energy Ltd (ORG):電力:M&Aディール及び事業提携情報
    Summary Origin Energy Ltd (Origin Energy) is an integrated energy company. It generates, supplies and distributes electricity; explores and develops natural gas reserves; and produces and sells gas. The company generates electricity from natural-gas fired, coal-fired, wind, solar, pumped water stora …
  • Nichias Corp (5393):企業の財務・戦略的SWOT分析
    Nichias Corp (5393) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • NIIT Ltd (NIITLTD):企業の財務・戦略的SWOT分析
    NIIT Ltd (NIITLTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆